Global Cancer Therapeutics Market Report - Forecasts to 2026

The findings reviewed by GME stated that the Global Cancer Therapeutics Market will expand at a CAGR value of 8.52% to reach USD 230.12 billion by 2026 from USD 140.22 billion by 2021. The factors supporting the cancer therapeutics market growth are the rising incidence of cancer across the globe, rising demand for personalized medicines, growing patient assistance programs (PAPS), and growing government initiatives for cancer awareness.

Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth TOC on “Global Cancer Therapeutics Market” - Forecast to 2026” https://www.globalmarketestimates.com/market-report/cancer-therapeutics-market-3370

By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others), By End-User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centre), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

Key Market Insights:
• The immunotherapy segment is expected to hold the largest shareholder of the market over the forecast period owing to its cancer-specificity while avoiding toxicity in non-target cells.
• The prostate cancer segment will be the fastest-growing segment with the highest CAGR value from 2021 to 2026.
• The Asia Pacific region will grow with the highest CAGR rate in the market
• F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, AbbVie, Inc., Johnson & Johnson, Celgene Corporation, Astellas Pharma, Inc., Pfizer, Inc., Novartis AG, Merck KGaA, Bayer AG, and Takeda Pharmaceutical Company Limited, among others are some of the key players in the market
• In January 2020, Merck KGaA successfully acquired ArQule Inc. Merck KGaA is recognized as a biopharmaceutical firm that focuses on kinase inhibitor development and discovery for the treatment of patients suffering from cancer.

Browse the Report @ https://www.globalmarketestimates.com/market-report/cancer-therapeutics-market-3370

Based on Therapy Outlook (Revenue, USD Billion, 2021 - 2026)
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy

Based on Application Outlook (Revenue, USD Billion, 2021 - 2026)
• Blood Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Others

Based on End-User Outlook (Revenue, USD Billion, 2021 - 2026)
• Hospitals
• Specialty Clinics
• Cancer and Radiation Therapy Centre

Regional Outlook (Revenue, USD Billion, 2021 – 2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Chile
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• South Africa
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: [email protected]
Phone Number: +16026667238
Website: Global Market Estimates
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php